ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HOTH Hoth Therapeutics Inc

1.21
0.00 (0.00%)
Pre Market
Last Updated: 21:46:04
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Hoth Therapeutics Inc HOTH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.21 21:46:04
Open Price Low Price High Price Close Price Previous Close
1.21
more quote information »

Recent News

Date Time Source Heading
01/5/202422:00PRNUSHoth Therapeutics to Attend EF Hutton Annual Global..
28/3/202405:00PRNUSHoth Therapeutics Announces Exercise of Warrants for $4.2..
27/3/202423:27PRNUSHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai,..
19/3/202423:21PRNUSHoth Therapeutics Announces Positive Data In Completed Study..
01/3/202400:38PRNUSHoth Therapeutics Retains Venable LLP to Expand Its Patent..
27/2/202400:11PRNUSHoth Therapeutics Engages Altasciences to Perform Key Study..
14/2/202403:45PRNUSHoth Therapeutics to Attend BIO CEO and Investor Conference,..
19/1/202400:20PRNUSHoth Therapeutics Announces it Received FDA Approval to..
10/1/202407:03EDGAR2Form 8-K - Current report
09/1/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202300:21PRNUSHoth Therapeutics Announces Expansion of FDA Cleared..
06/12/202300:33PRNUSHoth Therapeutics Announces it Has Successfully Completed..
15/11/202300:37PRNUSHoth Therapeutics Announces Successful Completion of Pre-IND..
14/11/202308:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202300:00PRNUSHoth Therapeutics to Present at NobleCon's 19th Annual..
06/10/202301:03PRNUSHoth Therapeutics Announces Merveille.ai Artificial..
05/10/202323:15EDGAR2Form 8-K - Current report
02/10/202323:33PRNUSFDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT,..
16/9/202306:15EDGAR2Form 8-K - Current report
16/9/202304:38PRNUSHoth Therapeutics Announces Closing of $2.89 Million..
15/9/202307:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/9/202303:43PRNUSHoth Therapeutics Announces $2.89 Million Registered Direct..
13/9/202322:16PRNUSHoth Therapeutics Announces Positive Results Killing Cancer..
12/9/202300:04PRNUSHoth Therapeutics Announces FDA Accepts Pre-Investigational..
06/9/202322:12PRNUSHoth Therapeutics Announces Positive Final Results from..
22/8/202307:10EDGAR2Form 8-K - Current report
22/8/202307:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:13PRNUSHoth Therapeutics Announces Positive Preclinical End Point..
25/7/202322:12PRNUSHoth Therapeutics Announces Major Milestone of First Patient..
19/7/202322:02PRNUSHoth Therapeutics Receives Protocol Approval for HT-001..
19/7/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202322:12PRNUSHoth Therapeutics Announces IRB Approval for FDA Cleared..
06/6/202322:02PRNUSHoth Therapeutics Announces Positive Preclinical Results of..
12/5/202322:38PRNUSHoth Therapeutics and Algorithm Sciences Terminate Letter of..

Your Recent History

Delayed Upgrade Clock